SCM
Sio Capital Management Portfolio holdings
AUM
$249M
This Quarter Return
+13.89%
1 Year Return
+117.71%
3 Year Return
+238.99%
5 Year Return
+411.91%
10 Year Return
+912.87%
AUM
$160M
AUM Growth
+$160M
(+51%)
Cap. Flow
+$50.9M
Cap. Flow
% of AUM
31.76%
Top 10 Holdings %
Top 10 Hldgs %
68.37%
Holding
60
New
15
Increased
12
Reduced
1
Closed
20
Top Buys
| 1 |
Gyre Therapeutics
GYRE
|
$24.5M |
| 2 |
Sanofi
SNY
|
$16.4M |
| 3 |
Biogen
BIIB
|
$8.74M |
| 4 |
Merck
MRK
|
$6.26M |
| 5 |
HCA Healthcare
HCA
|
$5.08M |
Top Sells
| 1 |
GSK
GSK
|
$11.6M |
| 2 |
QTNT
Quotient Limited Ordinary Shares
QTNT
|
$7.06M |
| 3 |
AET
Aetna Inc
AET
|
$4.47M |
| 4 |
Emergent Biosolutions
EBS
|
$4.25M |
| 5 |
Rigel Pharmaceuticals
RIGL
|
$3.43M |
Sector Composition
| 1 | Healthcare | 89.09% |
| 2 | Financials | 3.34% |
| 3 | Industrials | 0% |
| 4 | Technology | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Gyre Therapeutics
GYRE
$703M
| $29.7M | 17.83% | 1,149,989 +947,708 | +469% | +$24.5M |
|
|
2
Sanofi
SNY
$121B
| $16.4M | 9.84% | +408,621 | New | +$16.4M |
|
3
Kura Oncology
KURA
$686M
| $12.3M | 7.41% | 657,411 +265,384 | +68% | +$4.98M |
|
4
Elevance Health
ELV
$71.8B
| $11.5M | 6.92% | 52,387 +7,941 | +18% | +$1.74M |
|
|
5
Biogen
BIIB
$19.4B
| $8.74M | 5.25% | +31,900 | New | +$8.74M |
|
6
UnitedHealth
UNH
$281B
| $6.51M | 3.91% | 30,400 +18,970 | +166% | +$4.06M |
|
7
Eli Lilly
LLY
$657B
| $6.37M | 3.83% | 82,363 +28,463 | +53% | +$2.2M |
|
|
8
Merck
MRK
$210B
| $6.26M | 3.76% | +114,856 | New | +$6.26M |
|
9
Boston Scientific
BSX
$156B
| $6.16M | 3.7% | 225,463 +75,711 | +51% | +$2.07M |
|
10
Viking Therapeutics
VKTX
$3.04B
| $5.58M | 3.35% | 1,276,845 +26,595 | +2% | +$116K |
|
|
WCG
11
DELISTED
Wellcare Health Plans, Inc.
WCG
| $5.55M | 3.33% | 28,653 +5,453 | +24% | +$1.06M |
|
|
AET
12
DELISTED
Aetna Inc
AET
| $5.35M | 3.21% | 31,635 -26,454 | -46% | -$4.47M |
|
|
13
HCA Healthcare
HCA
$94.5B
| $5.08M | 3.05% | +52,330 | New | +$5.08M |
|
14
Icon
ICLR
$13.8B
| $4.28M | 2.57% | 36,200 +12,596 | +53% | +$1.49M |
|
15
Owens & Minor
OMI
$378M
| $4.26M | 2.56% | +273,640 | New | +$4.26M |
|
16
TruBridge
TBRG
$300M
| $3.33M | 2% | 113,860 +89,317 | +364% | +$2.61M |
|
|
CFMS
17
DELISTED
Conformis, Inc. Common Stock
CFMS
| $3.19M | 1.92% | +2,200,681 | New | +$3.19M |
|
18
Omnicell
OMCL
$1.5B
| $3.05M | 1.83% | +70,226 | New | +$3.05M |
|
19
Philips
PHG
$26.2B
| $2.94M | 1.77% | 76,742 +8,913 | +13% | +$341K |
|
20
Viatris
VTRS
$12.3B
| $2.84M | 1.71% | +69,000 | New | +$2.84M |
|
|
CELG
21
DELISTED
Celgene Corp
CELG
| $2.78M | 1.67% | +31,180 | New | +$2.78M |
|
22
MEI Pharma
MEIP
$160M
| $1.94M | 1.16% | 934,563 +107,650 | +13% | +$223K |
|
|
HRC
23
DELISTED
HILL-ROM HOLDINGS, INC.
HRC
| $1.87M | 1.12% | +21,449 | New | +$1.87M |
|
|
DERM
24
DELISTED
Dermira, Inc.
DERM
| $1.52M | 0.91% | +190,300 | New | +$1.52M |
|
|
EPZM
25
DELISTED
Epizyme, Inc
EPZM
| $1.29M | 0.78% | +72,826 | New | +$1.29M |
|